Qurient Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW1777 |
Market Cap |
KRW193.93 B |
Shares Outstanding |
7.68 M |
Public Float |
6.27 M |
Address |
8/F, Tower C, PDCC Building Seongnam GY 13487 Korea, Republic Of |
Employees | - |
Website | http://www.qurient.com |
Updated | 09/14/2018 |
Qurient Co., Ltd. engages in the development of novel therapeutics. Its research and development pipeline includes tuberculosis, atopic dermatitis, asthma and cancer. It offers drug development management and business development services. |